These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8286931)

  • 1. Commentary: regulatory issues affecting oligonucleotides.
    Crooke ST
    Antisense Res Dev; 1993; 3(3):301-6. PubMed ID: 8286931
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacology of therapeutic oligonucleotides.
    Diasio RB; Zhang R
    Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):239-43. PubMed ID: 9212918
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficiency of antisense oligonucleotide drug discovery.
    Bennett CF
    Antisense Nucleic Acid Drug Dev; 2002 Jun; 12(3):215-24. PubMed ID: 12162703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new antibiotics.
    Breithaupt H
    Nat Biotechnol; 1999 Dec; 17(12):1165-9. PubMed ID: 10585711
    [No Abstract]   [Full Text] [Related]  

  • 5. Perspectives in antisense therapeutics.
    Agrawal S; Iyer RP
    Pharmacol Ther; 1997; 76(1-3):151-60. PubMed ID: 9535177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming biological barriers to in vivo efficacy of antisense oligonucleotides.
    White PJ; Anastasopoulos F; Pouton CW; Boyd BJ
    Expert Rev Mol Med; 2009 Mar; 11():e10. PubMed ID: 19302730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense oligonucleotides for haematological malignancies.
    Cotter FE
    Haematologica; 1999 Jun; 84 Suppl EHA-4():19-22. PubMed ID: 10907458
    [No Abstract]   [Full Text] [Related]  

  • 8. Antisense 98: work in progress.
    Nat Biotechnol; 1998 Dec; 16(13):1319-21. PubMed ID: 9853610
    [No Abstract]   [Full Text] [Related]  

  • 9. Antisense therapeutics: is it as simple as complementary base recognition?
    Agrawal S; Kandimalla ER
    Mol Med Today; 2000 Feb; 6(2):72-81. PubMed ID: 10652480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nusinersen: First Global Approval.
    Hoy SM
    Drugs; 2017 Mar; 77(4):473-479. PubMed ID: 28229309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligonucleotides make sensible strides.
    Doran G
    Drug Discov Today; 2004 Feb; 9(3):114-6. PubMed ID: 14960388
    [No Abstract]   [Full Text] [Related]  

  • 12. Antisense strategies for oncogene inactivation.
    Stein CA; Benimetskaya L; Mani S
    Semin Oncol; 2005 Dec; 32(6):563-72. PubMed ID: 16338422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of antisense oligonucleotides for gene functionalization and target validation.
    Bennett CF; Cowsert LM
    Curr Opin Mol Ther; 1999 Jun; 1(3):359-71. PubMed ID: 11713801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides.
    Geary RS; Norris D; Yu R; Bennett CF
    Adv Drug Deliv Rev; 2015 Jun; 87():46-51. PubMed ID: 25666165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense oligonucleotide-based therapeutics for cancer.
    Dean NM; Bennett CF
    Oncogene; 2003 Dec; 22(56):9087-96. PubMed ID: 14663487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recruiting the 2-5A system for antisense therapeutics.
    Torrence PF; Xiao W; Li G; Cramer H; Player MR; Silverman RH
    Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):203-6. PubMed ID: 9212911
    [No Abstract]   [Full Text] [Related]  

  • 17. Technology evaluation: AVI-4126, AVI BioPharma.
    Stephens AC
    Curr Opin Mol Ther; 2004 Oct; 6(5):551-8. PubMed ID: 15537057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense oligonucleotides: towards clinical trials.
    Agrawal S
    Trends Biotechnol; 1996 Oct; 14(10):376-87. PubMed ID: 8987636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal muscular atrophy approval boosts antisense drugs.
    Dolgin E
    Nat Biotechnol; 2017 Feb; 35(2):99-100. PubMed ID: 28178250
    [No Abstract]   [Full Text] [Related]  

  • 20. Antisense oligonucleotides: a new therapeutic approach.
    Temsamani J; Guinot P
    Biotechnol Appl Biochem; 1997 Oct; 26(2):65-71. PubMed ID: 9357101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.